Serious clopidogrel associated renal hematoma in a type 2 diabetic patient with primary hyperparathyroidism after extracorporeal shock wave lithotripsy.
Renal hematoma after extracorporeal shock wave lithotripsy SWL is a rare complication. We report a case of a large renal hematoma following SWL that resulted in nephrectomy in a type 2 diabetic patient with primary hyperparathyroidism using clopidogrel due to coronary heart disease CHD. Although it was claimed that preoperative use of clopidogrel was not associated with increased bleeding, all patients who are scheduled for SWL should be interrogated in terms of using of platelet aggregation inhibitors such as clopidogrel, and these drugs should be interrupted appropriately before undergoing SWL.
Bahceci
Mithat
M
Department of Endocrinology, School of Medicine, Dicle University, Diyarbakir 21280, Turkey. mbahceci@dicle.edu.tr
Tuzcu
Alpaslan
A
Akay
Ferruh
F
Agil
Cuneyt
C
Akay
Hatice
H
D000077144:Clopidogrel; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006406:Hematoma / Q000209:etiology* / Q000601:surgery; D006801:Humans; D049950:Hyperparathyroidism, Primary / Q000150:complications*; D007669:Kidney Calculi / Q000209:etiology / Q000628:therapy; D007674:Kidney Diseases / Q000209:etiology* / Q000601:surgery; D008096:Lithotripsy / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives*
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine